Misonix to acquire Solys Medical, LLC
Clients Misonix, Inc.
Jones Day is advising Misonix, Inc. in its acquisition of Solsys Medical, LLC, a privately held regenerative medical company, in an all-stock transaction valued at approximately $97 million. Misonix is currently traded on the NASDAQ Global Market. In the transaction, each of Misonix and Solsys Medical will become subsidiaries of a new publicly traded holding company that is traded on the NASDAQ Global Market. It is anticipated that current shareholders of Misonix will own approximately 64 percent of the new holding company and current unitholders of Solsys will own approximately 36 percent. In connection with the transaction, Misonix received a binding commitment letter from lenders to expand and amend Solsys’s outstanding loan facilities upon completion of the transaction.